lixivaptan has been researched along with Adverse Drug Event in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Klunk, L; Li, Z; Orlandi, C; Prakash, C | 1 |
Howell, BA; Pellegrini, L; Shoda, LKM; Woodhead, JL | 1 |
2 other study(ies) available for lixivaptan and Adverse Drug Event
Article | Year |
---|---|
Assessment of exposure of metabolites in preclinical species and humans at steady state from the single-dose radiolabeled absorption, distribution, metabolism, and excretion studies: a case study.
Topics: Absorption; Adolescent; Adult; Animals; Area Under Curve; Benzamides; Carbon Radioisotopes; Case-Control Studies; Chromatography, High Pressure Liquid; Dogs; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Inactivation, Metabolic; Male; Metabolome; Middle Aged; Pyrroles; Rats; Rats, Sprague-Dawley; Young Adult | 2012 |
Comparison of the Hepatotoxic Potential of Two Treatments for Autosomal-Dominant Polycystic Kidney DiseaseUsing Quantitative Systems Toxicology Modeling.
Topics: Benzamides; Chemical and Drug Induced Liver Injury; Drug-Related Side Effects and Adverse Reactions; Humans; Models, Theoretical; Polycystic Kidney, Autosomal Dominant; Pyrroles; Tolvaptan | 2020 |